GC19277
PCI-27483
Also known as (2S)-2-[[2-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetyl]amino]butanedioic acid
PCI-27483 is a FVIIa/tissue factor inhibitor, with antitumour effects
ChemicalCAS871266-63-6MW596.57FormulaC26H24N6O9S
- CAS number
- 871266-63-6
- Molecular weight
- 596.57
- Formula
- C26H24N6O9S
- Solubility
- DMSO ： 62·5 mg/mL (104·77 mM)
- InChIKey
- WDJHHCAKBRKCLW-IBGZPJMESA-N
- Catalogue number
- GC19277
- Brand
- GLPBIO
Computed properties PubChem CID 135425273 · XLogP -0.1 · TPSA 291 Ų · H-bond donors 9
- XLogP
- -0.1
- TPSA
- 291 Ų
- H-bond donors
- 9
- H-bond acceptors
- 12
- Rotatable bonds
- 10
- Heavy atoms
- 42
SMILES C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)N[C@@H](CC(=O)O)C(=O)O
Computed descriptors from PubChem (CID 135425273), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il